Vivos Therapeutics (VVOS) announced a definitive agreement to acquire the operating assets of The Sleep Center of Nevada, SCN, the largest operator of medical sleep centers in Nevada. Vivos has agreed to pay up to $9 million for the SCN operating assets, including $6 million in cash and $1.5 million in Vivos common stock at closing. An additional $1.5 million in Vivos common stock may be earned in the future if SCN achieves an agreed to financial milestone. Vivos intends to secure the funding for the upfront cash payment primarily with a senior debt facility and also potential equity financing.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VVOS:
- Vivos Therapeutics’ Earnings Call Highlights Growth and Expansion
- Vivos Therapeutics price target lowered to $5.50 from $6 at Alliance Global Partners
- Vivos Therapeutics Reports Revenue Growth and Strategic Shift
- VVOS Earnings this Week: How Will it Perform?
- Vivos Therapeutics expands strategic alliance with Rebis Health